Építés alatt – nem éles oldal
Belépés

What researchers published on Huntington-kór

5998 papers, newest first.

Showing 100 of 5998

  • Expression of Concern for SHMT2 deficiency disrupts transcriptional regulation through homocysteine-mediated suppression of histone lactylation in Huntington's disease models.The Journal of clinical investigation
  • Computer vision-aided locomotor behavioral analysis identifies therapeutic motor signatures in a mouse model of Huntington's disease.Pharmacological research
  • Psychometric validation of the Spanish version of the Huntington's Disease Health-Related Quality of Life Questionnaire (HDQoL©).Clinical neurology and neurosurgery
  • Repairing the disruption of protein homeostasis ameliorates REM sleep dysfunction in mouse models of Huntington's disease.Sleep
  • ÁttekintésPharmacological strategies to manage oxidative stress in Huntington's disease: from preclinical models to clinical trials.Frontiers in pharmacology
  • Superpixel-ComBat multi-site harmonization of unpaired T1W MRI data in Huntington's disease.Neuroimage. Reports
  • Interoception predicts empathy, social anxiety and quality of life in Huntington's disease.Journal of neurology
  • Sustained Improvements in Chorea Associated with Huntington Disease with Once-Daily Valbenazine: Interim Results from a Long-Term Open-Label Study.CNS spectrums
  • ÁttekintésMiro1 and mitochondrial dysfunction in Huntington's disease: Emerging mechanistic links and therapeutic perspectives.Mitochondrion
  • Qualitative insights from partners of individuals with Huntington's disease: the quality of life of an under-researched population.Orphanet journal of rare diseases
  • Primer site variations resulting in false-negative Huntington's disease testing.Journal of medical genetics
  • Isozyme-Specific Inhibition of GSK-3 Reveals Distinct Cellular Responses in Huntington's Disease Fibroblasts.Journal of neurochemistry
  • The SorCS2-derived macrocycle TT-P34 drives neuroprotection in animal models of neurodegeneration.Acta neuropathologica communications
  • ÁttekintésThe hepatic secretome-microglia axis in huntington's disease: Linking peripheral metabolic dysfunction to neuroinflammation and novel therapeutic opportunities.Metabolic brain disease
  • In vivo assessment of brain microstructure in patients with Huntington's disease using quantitative MRI.Journal of neurology
  • NeuroD1-induced fate conversion partially restores GABAergic neuronal identity in Huntington's disease.Molecular therapy : the journal of the American Society of Gene Therapy
  • Forecasting and Dynamics of Huntington's disease: A Machine Learning approach for Fractional-Order Mathematical Model.Journal of advanced research
  • The Treatment of Psychiatric Symptoms in Huntington's Disease: A Systematic Review.Current neuropharmacology
  • Rhes as a Potential Modulator of PINK1/Parkin-Dependent Mitophagy in Huntington's Disease.Journal of integrative neuroscience
  • The postsynaptic scaffolding protein SAPAP3 shapes mitochondrial activity: the case of Huntington's disease.Cell death & disease
  • Cell-specific transcription dysregulation in human Huntington's disease-positive developing striatum.Brain : a journal of neurology
  • Bioinformatics Analysis to Reveal Potential Targets of Huntington's Disease.IET systems biology
  • CSF Leukocytes Transiently Increase Before Onset of Huntington Disease in Association With a Stage-Specific CSF Cytokine/Chemokine Pattern.Neurology(R) neuroimmunology & neuroinflammation
  • Computational modeling and preclinical evaluation support targeting somatic instability for Huntington's disease treatment.Nature communications
  • Somatic DNA-repeat expansions initiate distinct yet analogous changes in Huntington's disease cortical and striatal neurons.Cell
  • Multimodal spatial transcriptomics redefines cortical pathology in Huntington's disease.Cell
  • ÁttekintésNeuroprotective roles of Klotho signaling in Huntington's disease: From molecular insights to clinical translation.IBRO neuroscience reports
  • Early Administration of Methylene Blue Attenuates Mitochondrial Dysfunction and Cognitive Deficits in a Model of Huntington's Disease.Biology
  • Should Huntington's Disease Remains the First Genetic Consideration in Adults Presenting with Combined Chorea and Ataxia in Resource-Limited Settings?Movement disorders clinical practice
  • Quantifying multidisciplinary collaboration in Huntington's disease before and after service redesign: a social network analysis.BMC health services research
  • HD-DRUM Rhythmic Training in Huntington's Disease: Feasibility, Motor, and Brain Microstructural Pilot Signals.Movement disorders clinical practice
  • PreprintCerebrospinal Fluid Myeloperoxidase Is Associated With Putamen Volume Beyond Neurofilament Light in Huntington's Disease.medRxiv : the preprint server for health sciences
  • Randomizált vizsgálatAntidopaminergic Medications and Clinical Outcomes in Huntington Disease: Evidence From the PROOF-HD Placebo-Controlled Trial.Neurology
  • Healthcare trajectories diverge years before Huntington disease is recorded in claims: a nationwide French matched cohort study.Journal of neurology, neurosurgery, and psychiatry
  • Emotion regulation difficulties are selectively associated with executive and behavioural apathy in Huntington's disease.Journal of neurology
  • Beyond Clinical Outcomes: What Antidopaminergic Medications Teach Us About Causal Inference in Huntington Disease.Neurology
  • Progenitor transcriptional alterations link fetal and adult pathology in Huntington's disease.Brain : a journal of neurology
  • ÁttekintésBeyond inherited repeat length: somatic expansions in Huntington disease.Current opinion in genetics & development
  • Cas9 nickase-mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model.Science translational medicine
  • ÁttekintésThe potential of AI inspired approaches for patient monitoring in drug development for Huntington's disease: capturing the digital exhaust for activities of daily living.Frontiers in molecular medicine
  • Autonomic dysfunction in patients with Huntington's disease: Evidence from standardized cardiovascular reflex testing.Journal of Huntington's disease
  • Huntington's disease clinical trials update: August 2026.Journal of Huntington's disease
  • ÁttekintésNeuroprotective Role of Withaferin A in Huntington's Disease: Current Evidence and Future Perspectives.Molecular neurobiology
  • The Power of Two: Combined MSH3/HTT Silencing in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • iPSC neurodegenerative disease initiative isogenic CAG repeat iPSC line for Huntington's disease.Journal of Huntington's disease
  • Attentional emotional bias in Huntington's disease: The "Hyper-Positive" effect.Cognitive, affective & behavioral neuroscience
  • Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross-Sectional Multimodal Analysis.Movement disorders : official journal of the Movement Disorder Society
  • Recent Advances in Pharmacological Interventions for Huntington's Disease: Evidence from Clinical Translation.Reviews on recent clinical trials
  • Huntington's disease vasculopathy is barrier-type-selective and arteriolar-dominant with spatially-coupled astrogliosis and reversible by S1pr1 stimulation.Nature communications
  • Unmasking Huntington Disease: How a Neuropsychiatric Crisis Overcame Cultural Barriers to a Delayed Diagnosis.Clinical case reports
  • Role of Miro1 in Mitochondrial Dysfunction and Neurodegeneration in Huntington's Disease.Current neurovascular research
  • EsetismertetésJuvenile Huntington Disease With Cerebellar-Predominant Atrophy Identified by Genome Sequencing.Annals of clinical and translational neurology
  • Striatal astrocyte μ-crystallin (Crym) loss contributes to early-stage Huntington's disease pathophysiology.Neuron
  • Plasma Lipid Remodeling across Preclinical Burden, Disease Onset, and Early Motor Severity in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society
  • PreprintEffect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD.medRxiv : the preprint server for health sciences
  • Safety and efficacy of SOM3355 in patients with Huntington's disease (SOMCT03): a phase 2b, randomised, placebo-controlled, multicentre, dose-ranging study.EClinicalMedicine
  • PreprintDepletion of border-associated macrophages impairs CSF flow and exacerbates extranuclear mutant Huntingtin aggregation in the zQ175DN mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • Pellagra encephalopathy in Huntington disease: An autopsy case.Journal of neuropathology and experimental neurology
  • Joint Analysis for Multivariate Longitudinal and Event Time Data With a Change Point Anchored at Interval-Censored Event Time.Statistics in medicine
  • Staging disease without illness: ethical issues of the Huntington's Disease Integrated Staging System (HD-ISS).Journal of medical ethics
  • ÁttekintésMonitoring huntingtin aggregation in Huntington's disease: methods, challenges and future opportunities.Expert review of proteomics
  • ÁttekintésExtracellular Vesicles and Exosomes as Biomarkers in Huntington's Disease: Uncovering Pathogenic Insights and Pioneering Therapies.Molecular neurobiology
  • ÁttekintésHope or hype: novel disease-modifying treatments for Huntington disease.Parkinsonism & related disorders
  • Nationwide survey and epidemiology of Huntington's disease in Hungary.Neuroepidemiology
  • Lycium barbarum glycopeptide alleviates the neuropathology in Huntington's disease mouse models.Neural regeneration research
  • ÁttekintésChaperone-mediated remodelling of mutant huntingtin.Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • ÁttekintésMechanistic Differences in Adult-Onset and Juvenile-Onset Huntington's Disease and the Potential Role of Neurodevelopment.Cureus
  • PreprintRestoring Aquaporin-4 alleviates molecular and motor phenotypes in zQ175 mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • PreprintComputer vision-aided locomotor behavioral analysis identifies therapeutic motor signatures in a mouse model of Huntington's disease.bioRxiv : the preprint server for biology
  • Agentic AI for Clinical Outcomes Research, Population Health Management Analyses With Large Administrative Databases, and Generating Epidemiological Estimates of Diseases: Feasibility and Validation Study.Journal of medical Internet research
  • ÁttekintésZebrafish as an Alternative Animal Model of Huntington's Disease: Challenges and Future Directions.Journal of integrative neuroscience
  • Development of Antisense Gapmers for the Treatment of Huntington's Disease.Methods in molecular biology (Clifton, N.J.)
  • Sex-dependent mild cardiac dysfunction and neurometabolic abnormalities in a model of Huntington's disease.Disease models & mechanisms
  • ÁttekintésEstrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington's disease.Neurodegenerative disease management
  • Masking phosphatidylserine prevents neuronal loss in two distinct Drosophila models of neurodegeneration.Proceedings of the National Academy of Sciences of the United States of America
  • Expression of mutant Huntingtin induces proteasomal defects, mitochondrial abnormalities, and cell death in Drosophila muscles.Biochemical and biophysical research communications
  • ÁttekintésPlanning advanced therapy trials for Huntington's disease: Ethical considerations.Molecular therapy : the journal of the American Society of Gene Therapy
  • Correction: Remote smartphone-based spoken language screening predicts clinical markers in Huntington's disease.Journal of neural transmission (Vienna, Austria : 1996)
  • ÁttekintésUncovering hidden protein networks in Huntington's disease: implications for pathogenesis and therapy.Molecular biology reports
  • Exploring factors that influence meal management and eating behaviours in people living with Huntington's disease.Disability and rehabilitation
  • ÁttekintésDefective membrane dynamics in Huntington's disease: A role of Rab11 dysfunction.Journal of Huntington's disease
  • EsetismertetésChorea-predominant SCA5 mimicking Huntington's disease: A case report with a novel SPTBN2 variant.Clinical parkinsonism & related disorders
  • miR-196a reduces mutant Huntingtin aggregates by Rad23b-mediated degradation in Huntington's disease.Journal of biomedical science
  • ÁttekintésFluid and Imaging Biomarkers in Huntington's Disease.Current neurology and neuroscience reports
  • ÁttekintésImaging the glymphatic system in Huntington's disease: The benefits of a multimodal approach and clinical implications.International review of neurobiology
  • ÁttekintésIndoleamine 2,3-dioxygenase 1 inhibitors: Molecular pharmacology, structural biology and medicinal chemistry with therapeutic perspectives for Huntington's disease.Biochimica et biophysica acta. Proteins and proteomics
  • uniQure Submits U.S., U.K. Applications for Huntington's Disease Candidate.Human gene therapy
  • Esketamine for treatment of depression in Huntington's disease: A case report.Journal of Huntington's disease
  • Meal timing as medicine: clinical evidence for intermittent fasting in Huntington's disease.Nature metabolism
  • Vizsgálati eredményEffects of time-restricted eating in early-stage Huntington's disease: a pilot study.Nature metabolism
  • Visualizing Synaptic Disruptions in the Release and Regulation of Dopamine Hotspots in Huntington's Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience
  • An Atlas of Modifiers of Age at Onset in Huntington's Disease.Current neuropharmacology
  • Loss of interruption in the HTT CAG repeat is associated with somatic expansion and loss of medium spiny neurons in Huntington's disease.Neuron
  • Decreased cerebrospinal fluid TNFRSF8 (sCD30) confirmed as a biomarker of Huntington's disease progression.Journal of neurology
  • The Trail Making Test in healthy controls and Huntington's disease: Demographic effects and normative tables based on a large data set.Psychological assessment
  • Evaluation of curcumin as an exploratory pharmacological tool for modulating dysregulated molecular pathways in cellular models of Huntington's disease.Molecular biology reports
  • Neuroimaging Findings in Three Patients with Juvenile Huntington's Disease.AJNR. American journal of neuroradiology
  • ÁttekintésMicroRNAs in polyglutamine diseases: Mechanistic insights, circulating biomarkers, and emerging microRNA-based therapeutic strategies.Neurobiology of disease
  • Sesamum indicum-derived valdiate as a novel neuroprotective agent targeting PDE10A2 and SIRT1 in Huntington's disease.Frontiers in bioinformatics
  • Combining Lycopene, Quercetin, and Poloxamer 188 Therapy Reduces Learning and Memory Deficits in the 3-nitropropionic Acid-induced Rat Model of Huntington's Disease.CNS & neurological disorders drug targets